Alpha-synuclein: Stopping the Sticky Protein behind Parkinson's
|Thursday, November 17, 12 to 1 p.m. ET|
Nearly everyone with Parkinson's has clumps of the protein alpha-synuclein in brain cells, which researchers believe may lead to disease symptoms and progression. Our panelists will discuss clinical trials of therapies to prevent or treat those clumps and protect cells, as well as what we know about this key protein.
Q & A with participants will follow the discussion.
Thank you to our 2016 Parkinson's Disease Education Consortium Steering Committee members. While our generous sponsors make our educational offerings possible, their support does not influence MJFF's content, perspective or panelist selection.
The Michael J. Fox Foundation
Grand Central Station, P.O. Box 4777
New York, NY 10163-4777